In this review, we discuss the discovery and biologic significance of HE4 and evaluate available evidence regarding the utility of HE4 as a biomarker for ovarian and endometrial cancer.
Archana R. Simmons, PhD
Advertisement
Articles by Archana R. Simmons, PhD
Advertisement
Latest Updated Articles
The Emerging Role of HE4 in the Evaluation of Epithelial Ovarian and Endometrial CarcinomasPublished: June 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Oral SERD Regimen May Prolong Efficacy in Second-Line Breast Cancer Care
3
Frontline Immunotherapy Improves OS Vs BRAF/MEK Inhibitors in BRAF+ NSCLC
4
FDA Issues CRL for Dasatinib in CML/ALL
5
